Lem-14-1189, a LEM-14 derivative, is a potent NSD inhibitor of the nuclear receptor binding SET domain, and has inhibitory effects on NSD1, NSD2, and NSD3, with IC50 of 418 µM, 111 µM, and 60 µM, respectively. LEM-14-1189 has potential anticancer activity and can be used to study multiple myeloma (MM) and diseases of the blood system.
Molecular Weight:
682.81
Purity:
98.06%
CAS Number:
[2987501-17-5]
Formula:
C35H34N6O5S2
Target:
Histone Methyltransferase
T72979
* VAT and and shipping costs not included. Errors and price changes excepted
